Jennison Associates’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $16.8M | Buy |
|
|||||
|
2023
Q2 | $15.7M | Buy |
|
|||||
|
2023
Q1 | $16.6M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $27.4M | Buy |
|
|||||
|
2021
Q3 | $5.04M | Sell |
|
|||||
|
2021
Q2 | $4.83M | Sell |
|
|||||
|
2021
Q1 | $4.63M | Sell |
|
|||||
|
2020
Q4 | $414M | Sell |
|
|||||
|
2020
Q3 | $366M | Buy |
|
|||||
|
2020
Q2 | $93.6M | Sell |
|
|||||
|
2020
Q1 | $75.9M | Buy |
|
|||||
|
2019
Q4 | $99.4M | Sell |
|
|||||
|
2019
Q3 | $82.8M | Buy |
|
|||||
|
2019
Q2 | $152M | Sell |
|
|||||
|
2019
Q1 | $120M | Sell |
|
|||||
|
2018
Q4 | $112M | Sell |
|
|||||
|
2018
Q3 | $197M | Buy |
|
|||||
|
2018
Q2 | $160M | Sell |
|
|||||
|
2018
Q1 | $98.3M | Buy |
|
|||||
|
2017
Q4 | $64M | Buy |
|
|||||
|
2017
Q3 | $51.9M | Buy |
|
|||||
|
2017
Q2 | $18.9M | Sell |
|
|||||
|
2017
Q1 | $16.7M | Hold |
|
|||||
|
2016
Q4 | $15.5M | Sell |
|
|||||
|
2016
Q3 | $85.6M | Buy |
|
|||||
|
2016
Q2 | $19.9M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $32.4M | Buy |
|
|||||
|
2015
Q3 | $4.78M | Sell |
|
|||||
|
2015
Q2 | $10.7M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $21.6M | Buy |
|